Relvar Ellipta contains two medicines, fluticasone furoate and vilanterol. Relvar Ellipta is a long-acting bronchodilator combined with an inhaled corticosteroid that is taken once daily for the treatment of asthma and COPD.
This link will take you to www.medicines.ie which is a non-GSK website.
This guide can help you make the most of your treatment, but if you have any questions or concerns just ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Website: www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.
Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies
March 2019 IE/FFT/0002/16e(2)
To report an adverse event or any other general enquiry.